Home - Products - Others - Other Targets - Peptide YY (13-36) (canine, mouse, porcine, rat)

Peptide YY (13-36) (canine, mouse, porcine, rat)

CAS No. 86895-09-2

Peptide YY (13-36) (canine, mouse, porcine, rat)( ——— )

Catalog No. M40065 CAS No. 86895-09-2

Peptide YY (13-36) (canine, mouse, porcine, rat) is a Y2 receptor subtype agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Peptide YY (13-36) (canine, mouse, porcine, rat)
  • Note
    Research use only, not for human use.
  • Brief Description
    Peptide YY (13-36) (canine, mouse, porcine, rat) is a Y2 receptor subtype agonist.
  • Description
    Peptide YY (13-36) (canine, mouse, porcine, rat) is a Y2 receptor subtype agonist.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    86895-09-2
  • Formula Weight
    3014.4
  • Molecular Formula
    C135H209N41O38
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. D A Keire, et al. Primary structures of PYY, Pro(34)PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol. 2000 Jul;279(1):G126-31.?
molnova catalog
related products
  • D-Glucose 6-phosphat...

    In cells D-glucose 6-phosphate (G6P) is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by phosphoglucomutase during glycogenolysis. G6P lies at the beginning of both glycolysis and the pentose phosphate pathways. It also can be stored as glycogen when blood glucose levels are high.

  • Anhydrolutein I

    Anhydrolutein I

  • Brr2 Inhibitor C9

    Brr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).